Biotricity, Inc. (BTCY)
OTCMKTS · Delayed Price · Currency is USD
0.4902
-0.0596 (-10.84%)
Oct 6, 2025, 3:46 PM EDT
Biotricity Market Cap
Biotricity has a market cap or net worth of $13.88 million as of October 6, 2025. Its market cap has increased by 104.28% in one year.
Market Cap
13.88M
Enterprise Value
42.45M
Revenue
14.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.49
Market Cap Chart
Since February 18, 2016, Biotricity's market cap has decreased from 187.13M to 13.88M, a decrease of -92.58%. That is a compound annual growth rate of -23.65%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 6, 2025 | 13.21M | 85.63% |
Dec 31, 2024 | 7.12M | -31.33% |
Dec 29, 2023 | 10.37M | -61.10% |
Dec 30, 2022 | 26.65M | -88.14% |
Dec 31, 2021 | 224.72M | 464.80% |
Dec 31, 2020 | 39.79M | 13.76% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Feb 18, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Elite Pharmaceuticals | 686.89M |
Glass House Brands | 644.95M |
Veradigm | 511.83M |
Northwest Biotherapeutics | 382.92M |
Nika Pharmaceuticals | 333.67M |
CytoDyn | 326.79M |
American Oncology Network | 281.53M |
Silence Therapeutics | 236.17M |